Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron

Anesthesiology

Volumn 102, Issue 6, 2005, Pages 1094-1100

  Charbit, Beny ^a,b   Albaladejo, Pierre ^a   Funck Brentano, Christian ^a,b   Legrand, Mathieu ^a   Samain, Emmanuel ^a,c   Marty, Jean ^a  

^a BEAUJON HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; DROPERIDOL; ONDANSETRON; SEROTONIN 3 ANTAGONIST;

ADULT; ANESTHESIA DURATION; ARTICLE; BODY TEMPERATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PATIENT MONITORING; POSTOPERATIVE NAUSEA; POSTOPERATIVE VOMITING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT INTERVAL; QT PROLONGATION; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE;

ADULT; DROPERIDOL; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; ONDANSETRON; POSTOPERATIVE NAUSEA AND VOMITING; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 19744377392     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200506000-00006     Document Type: Article

References (30)

1. Roden DM: Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350:1013-22
2. Michaloudis DG, Kanakoudis FS, Petrou AM, Konstantinidou AS, Pollard BJ: The effects of midazolam or propofol followed by suxamethonium on the QT interval in humans. Eur J Anaesthesiol 1996; 13:364-8
3. Kuenszberg E, Loeckinger A, Kleinsasser A, Lindner KH, Puehringer F, Hoermann C: Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. Eur J Anaesthesiol 2000; 17:662-4
4. Schmeling WT, Warltier DC, McDonald DJ, Madsen KE, Atlee JL, Kampine JP: Prolongation of the QT interval by enflurane, isoflurane, and halothane in humans. Anesth Analg 1991; 72:137-44
5. Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, Kovac A, Philip BK, Sessler DI, Temo J, Tramer MR, Watcha M: Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97:62-71
6. Boike SC, Ilson B, Zariffa N, Jorkasky DK: Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adults. Am J Health Syst Pharm 1997; 54:1172-6
7. Benedict CR, Arbogast R, Martin L, Patton L, Morrill B, Hahne W: Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers. J Cardiovasc Pharmacol 1996; 28:53-9
8. Lischke V, Behne M, Doelken P, Schledt U, Probst S, Vettermann J: Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 1994; 79:983-6
9. Bailey P, Norton R, Karan S: The FDA droperidol warning: Is it justified? ANESTHESIOLOGY 2002; 97:288-9
10. Gan TJ, White PF, Scuderi PE, Watcha MF, Kovac A: FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: Is it justified? (letter). ANESTHESIOLOGY 2002; 97:287
11. Shafer SL: Safety of patients reason for FDA black box warning on droperidol. Anesth Analg 2004; 98:551-2
12. Chang N, Simone A, Schultheis L, Rappaport B: Reviewing case reports and the droperidol warning: FDA response (letter). Anesth Analg 2003; 97:1542
13. Dershwitz M: There should be a threshold dose for the FDA black-box warning on droperidol. Anesth Analg 2003; 97:1542-3
14. Drolet B, Zhang S, Deschenes D, Rail J, Nadeau S, Zhou Z, January CT, Turgeon J: Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J Cardiovasc Electrophysiol 1999; 10:1597-604
15. Habib AS, Gan TJ: Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003; 96:1377-9
16. Kasinath NS, Malak O, Tetzlaff J: Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: A case report. Can J Anaesth 2003; 50:229-31
17. Baguley WA, Hay WT, Mackie KP, Cheney FW, Cullen BF: Cardiac dysrhythmias associated with the intravenous administration of ondansetron and metoclopramide. Anesth Analg 1997; 84:1380-1
18. Charbit B, Becquemont L, Lepere B, Peytavin G, Funck-Brentano C: Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrine. Clin Pharmacol Ther 2002; 72:514-23
19. Gill JS, Zezulka AV, Beevers DG, Davies P: Relation between initial blood pressure and its fall with treatment. Lancet 1985; 1:567-9
20. Booker PD, Whyte SD, Ladusans EJ: Long QT syndrome and anaesthesia. Br J Anaesth 2003; 90:349-66
21. Mattu A, Brady WJ, Perron AD: Electrocardiographic manifestations of hypothermia. Am J Emerg Med 2002; 20:314-26
22. Heath BM, Terrar DA: Separation of the components of the delayed rectifier potassium current using selective blockers of IKr and IKs in guinea-pig isolated ventricular myocytes. Exp Physiol 1996; 81:587-603
23. Martynyuk AE, Morey TE, Raatikainen MJ, Seubert CN, Dennis DM: Ionic mechanisms mediating the differential effects of methohexital and thiopental on action potential duration in guinea pig and rabbit isolated ventricular myocytes. ANESTHESIOLOGY 1999; 90:156-64
24. Chen X, Yamakage M, Yamada Y, Tohse N, Namiki A: Inhibitory effects of volatile anesthetics on currents produced on heterologous expression of KvLQT1 and minK in Xenopus oocytes. Vascul Pharmacol 2002; 39:33-8
25. Katchman A, McGroary K, Kilborn M, Kornick C, Manfredi P, Woosley R, Ebert S: Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther 2002; 303:688-94
26. Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D: Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther 2000; 295:614-20
27. Zhang Y, Luo Z, White P: A model for evaluating droperidol's effect on the median QTc interval. Anesth Analg 2004; 98:1130-5
28. Shah RR: The significance of QT interval in drug development. Br J Clin Pharmacol 2002; 54:188-202
29. Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM: What clinicians should know about the QT interval. JAMA 2003; 289:2120-7
30. Wolbrette D, Naccarelli G, Curtis A, Lehmann M, Kadish A: Gender differences in arrhythmias. Clin Cardiol 2002; 25:49-56